Aucun résultat
Dr. Christina Greenaway is an Infectious Disease physician, migrant health expert, and clinician-scientist in the Division of Infectious Diseases at the Jewish General Hospital, the J.D. MacLean Centre for Tropical Diseases, and a Principal Investigator at the Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, McGill University. Her research program aims to promote migrant health by identifying, quantifying, and addressing infectious disease disparities to improve prevention, diagnosis, and equitable access to care. Her work focusses on tuberculosis, viral hepatitis, and vaccine-preventable diseases among migrant populations. She has authored national and international screening and clinical guidelines for migrants, including those for Canada (CMAJ, 2011) and the European Centre for Disease Prevention and Control (ECDC, 2018, 2021). Dr. Greenaway has conducted large-scale retrospective cohort studies, systematic reviews, and economic evaluations to inform evidence-based policy and practice. She currently leads a multi-province, population-based study using linked administrative data to map the hepatitis B care cascade, quantify HBV burden, and model cost-effective screening and vaccination strategies for immigrants in Canada.
Dr. Christina Greenaway’s research focuses on reducing infectious disease disparities among migrants by integrating epidemiologic, clinical, and policy approaches to generate evidence that drives equitable public health and clinical practice.
Her specific areas of focus include:
Diefenbach-Elstob T, Tabrizi S, Rivest P, Benedetti A, Azoulay L, Schwartzman K, Greenaway C. IJTLD Open. 2025 Jan 1;2(1):45-52. doi: 10.5588/ijtldopen.24.0440.
Passos-Castilho AM, Murphy D, Blouin K, Benedetti A, Panagiotoglou D, Bruneau J, Klein M, Kwong J, Sander B, Janjua N, Greenaway C. Viruses. 2024 Mar; 16(3): 389.
Greenaway C, Greenwald ZR, Akaberi A, Song A, Passos-Castilho AM, Abou-Chakra NC, Palayew A, Alabdulkarim B, Platt R, Azoulay L, Brisson M, Quach C. Lancet Infect Dis. 2021 Jan;21(1):116-126.
Asundi A, Beliavsky A, Liu XJ, Akaberi A, Schwarzer G, Bisoffi Z, Requena-Méndez A, Shrier I, Greenaway C. Lancet Glob Health. 2019 Feb;7(2):e236-e248.
Pottie K, Greenaway C, Feightner J, Welch V, Swinkels H, Rashid M, Narasiah L, Kirmayer L, Ueffing E, MacDonald N, Hassan G, McNally C, Kahn K, Burhmann R, Dunn S, Dominic A, McCarthy AE, Gagnon A, Rousseau C, Tugwell P and the Canadian Collaboration for Immigrant and Refugee Health. CMAJ. 2011;183(12):E824-E925.
You have the power to make a difference! Your gift will support vital research at the Lady Davis Institute for Medical Research (LDI) that will translate into disease prevention, improved diagnoses, earlier detection, new and enhanced therapies, a better quality of life, wellness and hope for all of us.
Faire la différence, vous avez ce don! Votre contribution soutiendra la recherche essentielle menée à l’Institut Lady Davis qui permettra la prévention des maladies, des diagnostics plus précis, des dépistages plus rapides, des traitements innovants et plus performants, une meilleure qualité de vie, le bien-être et l’espoir pour nous tous.
Copyright © 2024 | Lady Davis Institute for Medical Research/Jewish General Hospital
Conception et développement : Yankee Media
